If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
557.00    -4.00 (-0.71%)
Bid:
558.50
Ask:
559.00
Spread: 0.50 (0.09%)
Market Cap: £2.47b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

9 Dec 2021 15:10

RNS Number : 1755V
Tate & Lyle PLC
09 December 2021
 

Tate & Lyle PLC

 

Notification of transaction by Person Discharging Managerial Responsibilities

Tate & Lyle PLC (the 'Company') announces that on 8 December 2021 the following Person Discharging Managerial Responsibilities ('PDMR') was granted options to purchase ordinary shares of 25p each in the capital of the Company ('Shares') under the Tate & Lyle Sharesave Plan 2020 at an exercise price of 542 pence per Share:

 

Name

No. of Sharessubject to option

Exercisable period

Nick Hampton

3,321

1 March 2025 - 31 August 2025

 

 

The notification below, which has been made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

 

Claire-Marie O'Grady

Company Secretary

9 December 2021

 

 

 

 

 

 

Notification and public disclosure of transactions by person discharging managerial responsibilities and persons closely associated with them

 

 

Details of PDMR / person closely associated with them ('PCA')

a)

Name

Nick Hampton

2.

Reason for the notification

a)

Position / status

Chief Executive

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tate & Lyle PLC

b)

LEI

2138008K14474WPKZ244

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

 

GB0008754136

b)

Nature of the transaction

Grant of a 3 year option over shares with an exercise price of 542 pence per share under the Tate & Lyle Sharesave Plan 2020

c)

Price(s) and volume(s)

Price(s)

Volume(s)

GBP 5.42

3,321

 

d)

Aggregated information

- Aggregated volume

- Price

 

 

3,321

 

GBP 17,999.82

e)

Date of the transaction

2021-12-08

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUKRVRAKUURAA
Date   Source Headline
18th May 202611:10 amRNS20260515_TATE & LYLE_8.5 EPT NON-RI_UK_BOFASE
18th May 202611:09 amRNS20260515_TATE & LYLE_8.5 EPT RI_UK_MLI
18th May 202611:02 amRNSForm 8.3 Tate & Lyle plc
18th May 202610:33 amRNSForm 8.5 (EPT/RI)
15th May 20263:20 pmRNSForm 8.3 - Tate & Lyle plc
15th May 20263:16 pmRNSForm 8.3 - Tate & Lyle plc
15th May 20263:12 pmRNSForm 8.3 - Tate & Lyle plc
15th May 20263:11 pmRNSForm 8.3 - Tate & Lyle plc
15th May 20262:53 pmRNSForm 8.3 Tate & Lyle Plc
15th May 20262:35 pmEQSForm 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
15th May 20261:52 pmRNSForm 8.3 Tate & Lyle plc
15th May 20261:15 pmRNSForm 8.3 - Tate & Lyle Plc
15th May 20261:14 pmRNSForm 8.5 (EPT/NON-RI)- TATE & LYLE PLC
15th May 20261:11 pmRNSForm 8.5 (EPT/NON-RI)-TATE & LYLE PLC
15th May 20261:10 pmRNSForm 8.3 TATE & LYLE PLC
15th May 202612:51 pmRNSForm 8.3 - Tate & Lyle Plc
15th May 202612:28 pmPRNInvesco Ltd: Form 8.3 - Tate & Lyle PLC; Opening Position disclosure
15th May 202612:23 pmRNSForm 8.3 - Tate & Lyle plc
15th May 202611:53 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
15th May 202611:35 amRNSForm 8.5 (EPT/RI)-Tate & Lyle plc
15th May 202611:29 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
15th May 202611:28 amGNWForm 8.3 - TATE & LYLE PLC
15th May 202611:28 amBUSForm 8.3 - TATE & LYLE PLC
15th May 202611:25 amRNSForm 8.3 - Tate & Lyle PLC
15th May 202611:20 amRNSForm 8.5 (EPT/NON-RI)-Tate & Lyle plc
15th May 202611:09 amRNSForm 8.3 - Tate & Lyle plc
15th May 202611:06 amRNS20260514_TATE & LYLE_8.5 EPT NON-RI_UK_BOFASE
15th May 202611:04 amRNS20260514_TATE & LYLE_8.5 EPT RI_UK_MLI
15th May 202610:56 amRNSForm 8.3 Tate & Lyle PLC
15th May 202610:49 amPRNForm 8.3 - Tate & Lyle PLC
15th May 202610:24 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - TATE & LYLE PLC - Ordinary Shares
15th May 202610:24 amBUSDimensional Fund Advisors Ltd. : Form 8.3 - TATE & LYLE PLC - Ordinary Shares
15th May 20268:56 amRNSForm 8.5 (EPT/RI)
14th May 20264:15 pmRNSPossible 595 pence all-cash offer for Tate & Lyle
14th May 20263:25 pmRNSForm 8.3 - Tate & Lyle plc
14th May 20261:24 pmRNSDisclosure Table
14th May 20261:07 pmRNSStatement re Possible Offer for Tate & Lyle
1st May 202610:00 amRNSTotal Voting Rights
1st Apr 20264:00 pmRNSHolding(s) in Company
27th Mar 20262:00 pmRNSHolding(s) in Company
13th Mar 20264:00 pmRNSHolding(s) in Company
2nd Mar 20262:00 pmRNSHolding(s) in Company
26th Feb 20267:00 amRNSTrading Statement
23rd Feb 202610:00 amRNSHolding(s) in Company
17th Feb 202612:00 pmRNSHolding(s) in Company
21st Jan 20267:00 amRNSDirectorate change
15th Jan 20269:00 amRNSHolding(s) in Company
12th Jan 202610:00 amRNSHolding(s) in Company
7th Jan 20264:30 pmRNSDirector/PDMR Shareholding
7th Jan 20262:30 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.